MET and cancer: The dysregulation of HGFR and/or MST1R were extensively implicated in multiple cancer oncogenic processes, such as proliferation, migration, invasion, angiogenesis, epithelial-to-mesenchymal transition (EMT) and drug resistance, etc.18–22